metronidazole has been researched along with vitamin k 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bachmann, C; Koletzko, B; Wendel, U | 1 |
| Berger, MR; Galle, PR; Gockel, I; Graf, C; Herzog, J; Lang, H; Möhler, M; Schimanski, CC; Theobald, M; Wehler, TC | 1 |
1 review(s) available for metronidazole and vitamin k 1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for metronidazole and vitamin k 1
| Article | Year |
|---|---|
Antibiotic therapy for improvement of metabolic control in methylmalonic aciduria.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Fatty Acids; Humans; Lincomycin; Male; Malonates; Methylmalonic Acid; Metronidazole; Vitamin K 1 | 1990 |
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Detergents; Exanthema; Fluoroquinolones; Gastrointestinal Neoplasms; Humans; Metronidazole; Minocycline; Prednisolone; Quinolizines; Retrospective Studies; Treatment Outcome; Vitamin K 1 | 2013 |